Laura Moylan, MD
Obstetrics & Gynecology · Dover, DENPI 1063496735
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,704 of the $2,483 with a category attached, or 68.6%. 25 manufacturers reported payments, led by Acessa Health Inc. at 38.8% of the total. Reporting peaked in 2019 at $1,234 and has fallen 96.8% since, to $39 in 2024.
Across 105 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acessa Health Inc.$964
- AbbVie$415
- Myovant Sciences Inc.$203
- Evofem Biosciences, Inc.$159
- Therapeuticsmd, Inc.$99
- Daiichi Sankyo Inc.$95
- plus $549 from 19 others
What the payments were for
- Travel & lodging$73530%
- Food & beverage$1,70469%
- Education$442%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acessa Health Inc. | 10 | $964 |
| AbbVie | 27 | $415 |
| Myovant Sciences Inc. | 16 | $203 |
| Evofem Biosciences, Inc. | 11 | $159 |
| Therapeuticsmd, Inc. | 5 | $99 |
| Daiichi Sankyo Inc. | 5 | $95 |
| Bayer | 6 | $91 |
| Urovant Sciences Inc | 2 | $46 |
| AMAG Pharmaceuticals, Inc. | 3 | $44 |
| Pacira Pharmaceuticals Incorporated | 1 | $39 |
| Davol Inc. | 2 | $37 |
| AstraZeneca | 2 | $35 |
| Organon | 1 | $34 |
| Merck | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $27 |
| Radius Health, Inc. | 1 | $26 |
| Aspira Women's Health Inc | 1 | $22 |
| Covidien LP | 1 | $19 |
| Exeltis, USA Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Pfizer | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
| Millicent US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acessa$735
How this compares
$2,483 in reported general payments places this provider in the 85th percentile of 139 obstetrics & gynecology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,415 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dover
- Robert HartmannDover$393K
- Robert ScacheriDover$5K
- Peter WongDover$4K
- Michelle CooperDover$3K
- Ian BaxterSeaford$157K
- Larry GlazermanWilmington$31K
- Anthony BellNewark$17K
- Richard DermanNewark$14K
- Steven BerlinLewes$7K
- Gordon OstrumNewark$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.